Location History:
- Brussells, BE (2005)
- Brussels, BE (2007)
Company Filing History:
2 out of 93 
1 out of 14 Years Active: 2005-2007
Title: Hervé Bazin: Innovator in Monoclonal Antibody Treatments
Introduction
Hervé Bazin is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. With a total of two patents to his name, Bazin's research focuses on methods to prevent and inhibit immune responses in human patients.
Latest Patents
Bazin's latest patents include a method of treatment with the anti-CD2 antibody LO-CD2b. This monoclonal antibody binds to baboon and human CD2, specifically targeting the LO-CD2b antibody. The application of this antibody is crucial in preventing and inhibiting immune responses mediated by the activation and proliferation of T-cells or natural killer cells. Another significant patent is related to the LO-CD2a antibody, which also aims to inhibit T cell activation and proliferation. This invention provides methods for using such antibodies to prevent graft rejection, graft versus host disease, or autoimmune diseases in human patients.
Career Highlights
Throughout his career, Bazin has worked with esteemed institutions such as Université Catholique de Louvain and Biotransplant, Inc. His research has been pivotal in advancing the understanding of immune responses and developing therapeutic strategies.
Collaborations
Bazin has collaborated with notable colleagues, including Dominique Latinne and Ruth A Kaplan. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Hervé Bazin's work in the field of monoclonal antibodies represents a significant advancement in immunology. His innovative patents and collaborations highlight his commitment to improving patient outcomes through scientific research.